‘Usually in Western stories, people who are crazy about curing all these diseases are the cause of the zombie phenomenon.’
Moderna Inc. is developing and beginning vaccine testing to treat the world’s 15 most worrying viruses by 2025.
According to sources, the US -based biotechnology company is sending available RNA (mRNA) technology to researchers who are working on new vaccines, and is leaving the Access mRNA vaccination program it has set up.
The statement was made by Moderna during the Global Pandemic Preparedness Summit conference sponsored by the United Kingdom (UK) government and the Coalition for Epidemic Preparedness Innovations (CEPI), an international coalition established five years ago to address future disease threats.
Moderna also said they were working with other partners, as well as opening up opportunities for new partners to develop vaccines that are capable of fighting the following pathogens:
Chikungunya
Crimean-Congo dengue fever
Dengue
Ebola
Malaria
Marburg
Lassa fever
MERS
COVID-19
Nipah virus
HIV
Moderna Chief Executive Officer (CEO) Stephane Bancel said that the viruses are a threat that has yet to be addressed by the world’s drugmakers.
For the record, during the early days of the Covid-19 pandemic that hit the world, Moderna had promised not to patent its vaccine.
As a result, it has prompted the manufacture of vaskin in Africa supported by the World Health Organization (WHO), Afrigen Biologics expanded to enable the vaccine to be given to poor and middle -income countries.
However, that doesn’t mean Moderna intends to share its vaccine technology with WHO -supported technology transfer hubs in South Africa, despite lobbying efforts by the organization.
In the meantime, the company said it would set up a manufacturing facility in Kenya, the first in Africa, to produce an mRNA vaccine against COVID-19.
It is part of Moderna’s future pandemic plan that aims to provide its technology to academic research laboratories, in order to test their vaccine theories to tackle emerging and existing diseases.
